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Brief Clinical ReportsThymoma-associated paraneoplastic encephalitis (TAPE): Diagnosis
and treatment of a potentially fatal conditionCherie Parungo Erkmen, MD,a Camilo E. Fadul, MD,b Josep Dalmau, MD, PhD,c and Kadir Erkmen, MD,d
Lebanon, NH, and Philadelphia, PaUp to 50% of patients with thymoma have paraneoplastic
neurologic syndromes, the most common being myasthenia
gravis.1 There are rare case reports of thymoma-associated
paraneoplastic limbic or extralimbic encephalitis that can
lead to progressive neurologic decline and death without
treatment. We report a case of a malignant thymoma pre-
senting as paraneoplastic encephalitis and review the clini-
cal characteristics, treatments used, and outcome of 28
patients with this disorder published according to a PubMed
and MEDLINE search (1950–2010).FIGURE 1. A, MRI of the head at presentation. White arrows show some
of the bilateral lesions. B, MRI of the head 3 months later, after immuno-
therapy and surgery C, Coronal CT of the chest showing malignant thy-
moma invading the innominate vein. D, Coronal CT of the chest 6 month
after surgery showing no residual disease. MRI, Magnetic resonance im-
age; CT, computed tomogram.CLINICAL SUMMARY
A previously asymptomatic 61-year-old woman had gen-
eralized intractable seizures. Brain magnetic resonance
imaging (MRI) showed bilateral foci of cortical and subcor-
tical nonenhancing signal abnormalities on T2-weighted
images (Figure 1, A). Chest computed tomography (CT) re-
vealed a large anterior mediastinal mass (Figure 1, C) that,
on biopsy, showed malignant thymoma. Analysis of cere-
brospinal fluid detected a predominantly lymphocytic pleo-
cytosis and positive LGI1 antibodies (previously known as
voltage-gated potassium channel antibodies).2
The patient received anticonvulsants, human intravenous
immunoglobulin G (IgG) (400 g/kg daily), and corticoste-
roids (methylprednisolone 1 gm daily) for 5 days plus
a prednisone taper with resolution of neurologic symptoms.
Four weeks later, the patient underwent complete, en bloc
resection of the mediastinal mass that was invading through
the pericardium (type B3, World Health Organization clas-
sification, Masaoka stage III). She received adjuvant radia-
tion therapy (5040 cGy) owing to suspected invasion into
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The Journal of Thoracic and Cadecrease in size of the brain lesions (Figure 1, B). Two years
after the operation, the patient has no evidence of tumor
recurrence (Figure 1, D) or neurologic impairment.DISCUSSION
Since 1988, when the first case of paraneoplastic enceph-
alitis in the setting of thymic cancer was reported, 28 cases
of thymoma-associated paraneoplastic encephalitis (TAPE)
have been described (Table 1). The encephalitis can be con-
fined to the limbic system or multifocal and extralimbic, as
in our case. In most patients (82%), neurologic manifesta-
tions include memory loss, confusion, and seizures. Seventy
percent exhibited bilateral foci of nonenhancing hyperin-
tensity on brain MRI, some appearing weeks after onset
of symptoms. The differential diagnosis includes metasta-
ses, primary brain tumors, and infection. The presence of
a mediastinal mass and pathologic confirmation ofrdiovascular Surgery c Volume 141, Number 2 e17
TABLE 1. Clinical features of thymoma-associated paraneoplastic encephalitis
Author Age/sex Symptoms Stage MRI, T2-weighted Pleocytosis
Antineuronal
antibodies Treatment Outcome
McArdle
(1988)
41/M Confusion, memory
deficit,
hallucinations
III No ANA (serum)
oligoclonal
IgG bands (CSF)
Partial thymectomy,
radiation,
corticosteroids
Death (1 mo)
Ingenito
(1990)
59/M Confusion, memory
deficit,
hypersomnolence
I Normal 13 WBC Corticosteroids Death (51 d)
Cunningham
(1994)
56/F Confusion, memory
deficit, emotional
lability
IVA Initially normal,
subsequent left
temporal lobe lesions
Thymectomy, radiation,
chemotherapy
No residual
symptoms
Antoine
(1995)
58/F Visual and auditory
hallucinations,
confusion
III Hyperintensity in right
hippocampus
Yes Antineuronal
cytoplasmic
(serum and CSF)
Thymectomy, radiation No residual
symptoms
Antoine
(1995)
67/F Confusion, agitation,
memory deficit,
hallucinations
II Hyperintensity
on right
No Antineuronal nuclear
(serum only, CSF
did not react)
Thymectomy, radiation Mild memory
deficit
Evoli
(1999)
32/M Confusion, memory
deficit, seizures
III Hyperintensity and
edema of bilateral
hippocampi
25 WBC Thymectomy, radiation,
chemotherapy,
corticosteroids,
plasmapheresis
Mild memory deficit,
dependent on
corticosteroids
Rickman
(2000)
55/M Malaise, dysarthria,
aphasia, seizures
II* Bilateral
hyperintensity
Yes AChR, CRMP5
(serum)
Partial thymectomy,
corticosteroids,
plasmapheresis
Residual
symptoms
D’Avino
(2001)
61/M Confusion, memory
deficit, irritable,
hallucinations
III Normal Antibody reactivity
to Perkinje cells
(serum and CSF)
Thymectomy, radiation Mild memory
deficit
Fujii
(2001)
55/M Confusion, memory
deficit, irritable,
mania, seizures
I* Bilateral high
intensity
No At autopsy,
hippocampus
showing
anti-human IgG
Thymectomy Death (4 mo)
Vernino
(2002)
66/F Hoarseness,
unilateral
loss of hearing,
areflexia
III ANNA-1, VGCC
(serum)
Partial thymectomy,
Chemotherapy
Death (7 mo)
Vernino
(2002)
34/M Dysarthria,
dysphagia
II Normal 10 WBC AChR, ANNA-1
(serum)
Thymectomy,
corticosteroids,
plasmapheresis
Residual symptoms,
memory deficit,
labile personality
Vernino
(2002)
34/F Vertigo, tinnitus,
vomiting
I Normal, 2.5 mo later
bilateral cortical
lesions
ANNA-1, VGKC
(serum)
Thymectomy Residual symptoms,
fixed right pupil
Vernino
(2002)
39/F Dysphagia,
weakness
III Normal ACHR, ANNA-1,
CRMP-5 (serum)
Partial thymectomy,
radiation,
chemotherapy,
corticosteroids,
plasmapheresis
Not reported
Ances
(2005)
44/F Confusion, memory
deficit,
combativeness
II Initially normal but
5 d later bilateral
temporal, cerebellar
lesions
Yes Neuropil reactivity
(serum and CSF)
Thymectomy,
corticosteroids, IgG
No residual
symptoms
Ances
(2005)
38/M Confusion, memory
deficit, agitation,
seizures
III Bilateral
nonenhancing
lesions
7 WBC Neuropil and GAD
(serum and CSF)
Thymectomy,
corticosteroids,
IgG, plasmapheresis
Memory deficit,
gait difficulty,
dependent on
corticosteroids
Chaudhry
(2007)
62/F Memory deficit,
cognitive
impairment
IVA Bilateral hipocampal
hyperintensity
Thymectomy,
chemotherapy,
rituimab monoclonal
antibody, plasmapheresis
Progressive
cognitive deficit
(Continued)
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TABLE 1. Continued
Author Age/sex Symptoms Stage MRI, T2-weighted Pleocytosis
Antineuronal
antibodies Treatment Outcome
Evoli
(2007)
Limbic encephalitis B2
Khella
(2007)
41/F Ataxia, dysarthria,
dementia
I Bilateral
hyperintensity
Yes NMDAR/VGKC
(serum and CSF)
Corticosteroids, IgG,
plasmapheresis
Death (31 mo)
Gesundheit
(2008)
28/M Auditory and visual
hallucinations,
incoherent speech
B2/II Subtle hyperintensity
of temporal lobes
Thymectomy, IgG No residual
symptoms
Graus (2008) 44/F Behavior change,
confusion
I* Not done Yes CV2 (CRMP5)
(serum and CSF)
Death (2 wk)
Lai (2009) 44/F Memory deficit,
confusion, seizure,
combativeness
II* Normal, 5 d later
increased temporal
lobe signal
44 WBC GluR2, ANA, dsDNA,
cardiolipin (serum
and CSF)
Thymectomy, IgG,
corticosteroids,
azathioprine
Residual short-term
memory deficit
Lai (2009) 38/M Memory deficit,
confusion, seizure,
agitation,
perseveration
II* Bilateral
hyperintense
lesions
7 WBC GluR2, GAD (serum
and CSF)
Thymectomy, radiation,
corticosteroids, IgG,
plasmapheresis
Residual short-term
memory deficit,
steroid-dependent
muscle spasms
and rigidity
Lai (2009) 44/F Confusion,
behavioral
change, gait
unsteadiness,
progressive
unresponsiveness
I* Normal 15 WBC GluR2, GluR1, CV2
(CRMP5) (serum
and CSF)
None, diagnosed
at autopsy
Death (24 mo)
Hammound
(2009)
43/F Seizure, confusion B2/II Minimally
enhancing
bilateral lesions
Yes AchR, VGKC
(serum)
Thymectomy, radiation,
chemotherapy,
corticosteroids, IgG
Death (2 mo)
Monstad
(2009)
49/F Memory deficit I Bilateral
hippocampal
lesions
10 WBC CRMP5, AchR
(serum)
Thymectomy,
corticosteroids,
plasmapheresis
Memory deficit
Rizzardi
(2009)
55/F Seizure, aphasia B/II Multiple, bilateral lesions
of insular, parietal,
and temporal lobes
Normal autoimmune
serologic exam
Thymectomy,
radiation
therapy
No residual
symptoms and
disease free
Werry
(2009)
32/M Vertigo, diplopia,
ataxia, myoclonic
jerking
B1/I Normal, 1 mo later
bilateral cortical
nonenhancing
hyperintensity
Mild
increase
CV2/CRMP-5
(serum)
Thymectomy,
corticosteroids,
IgG, plasmapheresis
Headache, fatigue,
and myasthenic
ptosis and double
vision
Erkmen
(2010)
61/F Seizure, memory
deficit
III Bilateral nonenhancing
hyperintense lesions
Yes VGKC, cell surface
antigen (CSF)
Thymectomy, radiation,
corticosteroids, IgG
No residual
symptoms
and disease free
MRI, Magnetic resonance imaging; ANA, antinuclear antibody protein-5; IgG, intravenous immunoglobulin G; CSF, cerebrospinal fluid; WBC, white blood cell count; AChR,
acetylcholine receptor; CRMP5, collapsin response mediator; ANNA-1, type 1 antineuronal nuclear antibody; VGCC, voltage-gated calcium channel; VGKC, voltage-gated po-
tassium channel; GAD, glutamic acid decarboxylase; NMDAR, N-methyl-D-aspartate receptor; CV2, crossveinless-2; GluR1,2, glutamate receptors 1, 2 subunits of alpha-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR); dsDNA, double stranded DNA. *Suspected staging based on author’s description. Thymoma being stage I;
thymic carcinoma being at least stage II or B3.
Brief Clinical Reportsthymoma would suggest a paraneoplastic syndrome.
Although routine analysis of cerebrospinal fluid is nonspe-
cific, sampling of serum and cerebrospinal fluid for anti-
neuronal antibodies (found in 75% of patients with
TAPE) will aid in establishing a paraneoplastic pathogene-
sis. There is little value in a brain biopsy inasmuch as it usu-
ally reveals nonspecific lymphocyte and plasma cell
infiltration. The diagnosis of TAPE depends on the combi-
nation of the encephalitis syndrome, MRI findings, and
detection of antineuronal autoantibodies in the setting of
a thymic neoplasm.The Journal of Thoracic and CaOnce the diagnosis of TAPE has been made, immediate
intervention is necessary to prevent progressive neurologic
decline and death. Immunotherapy with IgG and corticoste-
roids3 will improve neurologic symptoms resulting from
inflammatory response, but complete resection of the thy-
moma confers the best chance at disease-free survival
from oncologic as well as paraneoplastic standpoints. Anti-
body titers decrease after thymectomy, thus abating ongo-
ing inflammation and cell death.3 If corticosteroids, IgG,
and thymectomy fail to improve neurologic symptoms, di-
minishing antineuronal antibodies with plasmapheresisrdiovascular Surgery c Volume 141, Number 2 e19
Brief Clinical Reportsmay aid in management of these patients. The treatment of
TAPE must address the immune response targeting the ner-
vous system and the underlying thymoma.
Thirty-three percent of patients with TAPE died, all as
a consequence of the nervous system compromise. The ma-
jority of these patients who died had stage I thymomas.
Early Masaoka stage thymomas may produce more func-
tional and neurotoxic autoantibodies than their malignant
counterparts.4 Therefore, outcome is driven more by ongo-
ing neurologic insult than the underlying thymic disease.
Only 21% of patients with TAPE achieved symptom-free
survival; all of these patients had complete resection of their
thymoma.
With TAPE, it is incumbent on the clinician to make the
link between thymoma and encephalitis before progressive
neurologic symptoms and death ensue. The reported casesFrom the Department of Cardiovascular Surgery, Xin Qiao Hospital, the Third
Military Medical University, Chong Qing, China.
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e20 The Journal of Thoracic and Cardiovascular Surgsuggest a role of antineuronal autoantibody production in
the pathogenesis and, therefore, in the rationale for treat-
ment options.We believe that immunotherapy and complete
resection confer the best chance of symptom-free survival.References
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69-82.Total correction of tetralogy of Fallot associated with rhabdomyoma
in the right ventricleChuan Qin, MD, Lin Chen, MD, Ren-guo Wen, MD, and Ying-bin Xiao, MD, Chong Qing, ChinaPrimary cardiac tumors are a rare disease, with a low inci-
dence. Rhabdomyoma, a type of benign primary cardiac
tumor, is the most common primary cardiac neoplasm in
children and occurs almost exclusively in children. We
reported a rare case of an infant with tetralogy of Fallot as-
sociated with rhabdomyoma in the right ventricle.CLINICAL SUMMARY
An 8-month-old male infant had cyanosis and a heart
murmur at birth. Physical examination revealed cyanosis,
a systolic murmur at the second and third intercostal spaces
left of the sternum, and a weakened pulmonary second heart
sound. Transthoracic echocardiography showed typical an-
atomic appearance of tetralogy of Fallot and a 2 3 2-cm
mass in the right ventricular cavity. Multiple-slice com-puted tomography confirmed the findings from echocardi-
ography and revealed that the mass was likely to attach to
the right side of the interventricular septum (Figure 1). An
on-pump open cardiac operation was performed. Cardio-
pulmonary bypass was established by cannulation of the
aorta and venae cavae, and systemic temperature was kept
around 28C for the intracardiac procedure. Cold blood car-
dioplegia was used to induce and maintain cardiac arrest.
A longitudinal incision was made crossing the pulmonary
valve annulus, and the 2 3 2 3 1-cm mass was found
attached to the right side of interventricular septum close
to cardiac apex, surrounded by muscular trabeculae
(Figure 2, A). The base of the mass was about 1.5 3 1-cm
wide. This mass had a color similar to normal myocardium
with a smooth surface and irregular shape (Figure 2, B). The
cardiac mass was resected completely, with care taken to
cause as little injury to the normal myocardium as possible,
followed by correction of tetralogy of Fallot, including in-
fundibulectomy, repair of ventricular septal defect, and
transannular pericardial patch (Figure 2, C). This infant
was successfully weaned from cardiopulmonary bypass.
The mass was investigated pathologically. The immunohis-
tochemical assays showed that stainings of actin (Figure 2,
D), desmin, and vimentin were strongly positive. However,
staining of S-100 was negative. These histologic findings
proved that this cardiac mass was a rhabdomyoma. Duringery c February 2011
